AVAI
Avai Bio, Inc.Company with tickers: AVAI
Market Cap
$22.12M
Shares Outstanding
138,252,252
CIK
1740797
CUSIP
89487B100
Website
Visit website
Investor Relations
Investor relations
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Interest & Dividend Income | — | ||||
| Net Interest Income | — | ||||
| Noninterest Income | — | ||||
| Total Net Revenue | — | ||||
| Premiums Earned (Net) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $509,774 | USD | 2025-12-31 | 10-Q | 2026-02-12 |
| Research & Development | $23,804 | USD | 2025-12-31 | 10-Q | 2026-02-12 |
| Operating Income | $-553,727 | USD | 2025-12-31 | 10-Q | 2026-02-12 |
| Net Income | $-553,727 | USD | 2025-12-31 | 10-Q | 2026-02-12 |
| EPS (Basic) | $0.00 | USD/shares | 2025-12-31 | 10-Q | 2026-02-12 |
| EPS (Diluted) | — |